Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    Dr Lal PathLabs eyeing 18 per cent growth in FY17Dr Lal PathLabs eyeing 18 per cent growth in FY17
    FDA panel to vote whether diabetes drug cuts cardiac deathFDA panel to vote whether diabetes drug cuts cardiac death
    New code system to check fake medicines: Drug Controller General IndiaNew code system to check fake medicines: Drug Controller General India
    Fortis put on watch under implications by ICRAFortis put 'on watch under implications' by ICRA
    Cabinet withdraws Drugs and Cosmetic (Amendment) Bill, 2013Cabinet withdraws Drugs and Cosmetic (Amendment) Bill, 2013
    Govt to re-work UPAs drug regulatory billGovt to re-work UPA's drug regulatory bill
    Patanjali seeks Rs 1000 cr fiscal loan for expansionPatanjali seeks Rs 1000 cr fiscal loan for expansion
    Govt allows FDI up to 74 percent in brownfield pharma under automatic routeGovt allows FDI up to 74 percent in brownfield pharma under automatic route
    IIPA seeks level playing field for e-pharmacy spaceIIPA seeks level playing field for e-pharmacy space
    Mercks Keytruda prolongs life in big lung cancer studyMerck's Keytruda prolongs life in big lung cancer study
    Max Life and Max Fin Services to merge into HDFC Standard LifeMax Life and Max Fin Services to merge into HDFC Standard Life
    India : IFC to invest $75 m in GlenmarkIndia : IFC to invest $75 m in Glenmark
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    CDSCO to regulate Adhesives for fixing wigs, scalp cleansing products, artificial nails system, invites comments

    CDSCO to regulate Adhesives for fixing wigs, scalp cleansing products, artificial nails system,...

    FDC Ban: Avoid These Combinations of Paracetamol

    FDC Ban: Avoid These Combinations of Paracetamol

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok